| BCBS Highmark West Virginia | Skin Substitutes | 2026-10-01 |
| BCBS Highmark West Virginia | Enzyme Replacement Therapies | 2026-10-01 |
| HealthPartners | Oncology ** - denosumab and biosimilars | 2026-10-01 |
| UHC UMR Medical and Drug | Clotting Factors, Coagulant Blood Products, & Other Hemostatics – Commercial Medical Benefit Drug Policy | 2026-10-01 |
| UHC Surest Medical and Drug | Clotting Factors, Coagulant Blood Products, & Other Hemostatics – Commercial Medical Benefit Drug Policy | 2026-10-01 |
| UHC Commercial Medical & Drug | Autologous Cellular Therapy – Commercial and Individual Exchange Medical Policy | 2026-10-01 |
| UHC Commercial Medical & Drug | Bronchial Thermoplasty – Commercial and Individual Exchange Medical Policy | 2026-10-01 |
| UHC Commercial Medical & Drug | Cardiovascular Disease Risk Tests – Commercial and Individual Exchange Medical Policy | 2026-10-01 |
| UHC Commercial Medical & Drug | Category III Codes – Commercial and Individual Exchange Medical Policy | 2026-10-01 |
| UHC Commercial Medical & Drug | Cell-Free Fetal DNA Testing – Commercial and Individual Exchange Medical Policy | 2026-10-01 |